SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: D.Right who wrote (948)11/17/1997 9:49:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 2173
 
D. Right, I really don't see your distinction. Its an oversimplification that has little to do with reality. If it were so simple, AMLN would be getting ready to file an NDA, not do additional experiments for Type I and Type II patients. Both Pramlintide and Rezulin are hormone analogs designed to treat a hormone deficiency.